162 related articles for article (PubMed ID: 17972505)
1. Serum vascular endothelial growth factor in breast cancer.
Byrne GJ; McDowell G; Agarawal R; Sinha G; Kumar S; Bundred NJ
Anticancer Res; 2007; 27(5B):3481-7. PubMed ID: 17972505
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
Adams J; Carder PJ; Downey S; Forbes MA; MacLennan K; Allgar V; Kaufman S; Hallam S; Bicknell R; Walker JJ; Cairnduff F; Selby PJ; Perren TJ; Lansdown M; Banks RE
Cancer Res; 2000 Jun; 60(11):2898-905. PubMed ID: 10850435
[TBL] [Abstract][Full Text] [Related]
3. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
[TBL] [Abstract][Full Text] [Related]
4. Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
Iovino F; Ferraraccio F; Orditura M; Antoniol G; Morgillo F; Cascone T; Diadema MR; Aurilio G; Santabarbara G; Ruggiero R; Belli C; Irlandese E; Fasano M; Ciardiello F; Procaccini E; Lo Schiavo F; Catalano G; De Vita F
Cancer Invest; 2008; 26(3):250-5. PubMed ID: 18317965
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
[TBL] [Abstract][Full Text] [Related]
6. Circulating vascular endothelial growth factor during the normal menstrual cycle.
Kusumanto YH; Hospers GA; Sluiter WJ; Dam WA; Meijer C; Mulder NH
Anticancer Res; 2004; 24(6):4237-41. PubMed ID: 15736478
[TBL] [Abstract][Full Text] [Related]
7. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
8. Positive correlation between estradiol and vascular endothelial growth factor but not fibroblast growth factor-2 in normal human breast tissue in vivo.
Dabrosin C
Clin Cancer Res; 2005 Nov; 11(22):8036-41. PubMed ID: 16299233
[TBL] [Abstract][Full Text] [Related]
9. [Platelet activation and endothelial factors in standard exercise test before and after menopause].
Krzysiek J; Milewicz T; Dybkowski R; Janczak-Saif A; Dembińska-Kieć A; Anna AZ; Guevara I; Sztefko K; Radowicki S; Dubiel JS; Klimek R
Przegl Lek; 2001; 58(5):419-25. PubMed ID: 11603175
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Caine GJ; Stonelake PS; Lip GY; Blann AD
Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
[TBL] [Abstract][Full Text] [Related]
12. The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis.
Hormbrey E; Han C; Roberts A; McGrouther DA; Harris AL
Clin Cancer Res; 2003 Oct; 9(12):4332-9. PubMed ID: 14555503
[TBL] [Abstract][Full Text] [Related]
13. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
[TBL] [Abstract][Full Text] [Related]
14. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.
Sancak B; Coskun U; Gunel N; Onuk E; Cihan A; Karamercan A; Yildirim Y; Ozkan S
Intern Med J; 2004 Jun; 34(6):310-5. PubMed ID: 15228391
[TBL] [Abstract][Full Text] [Related]
15. [Change and clinic significance of serum VEGF level before and after breast cancer patients treated].
Jing J; Zhao YB; Li HJ; Lü Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):889-92. PubMed ID: 17236587
[TBL] [Abstract][Full Text] [Related]
16. Potential prognostic value of circulating levels of vascular endothelial growth factor-A in patients with gastric cancer.
Ding S; Lin S; Dong X; Yang X; Qu H; Huang S; Liu W; Zhou L; Liu D
In Vivo; 2005; 19(4):793-5. PubMed ID: 15999551
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients.
Tarnowski B; Chudecka-Głaz A; Górski B; Rzepka-Górska I
Breast Cancer Res Treat; 2004 Dec; 88(3):287-8. PubMed ID: 15609132
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
Manau D; Fábregues F; Peñarrubia J; Creus M; Carmona F; Casals G; Jiménez W; Balasch J
Hum Reprod; 2007 Mar; 22(3):669-75. PubMed ID: 17079244
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer.
Vicioso L; Gonzalez FJ; Alvarez M; Ribelles N; Molina M; Marquez A; Perez L; Matilla A; Alba E
Am J Clin Pathol; 2006 Jan; 125(1):111-8. PubMed ID: 16482999
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-C in patients with breast cancer.
Al-Mowallad A; Kirwan C; Byrne G; McDowell G; Li C; Stewart A; Al-Qouzi A; Kumar S
In Vivo; 2007; 21(3):549-51. PubMed ID: 17591368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
